Cargando…

Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?

Early diagnosis of malignant pleural mesothelioma (MPM) is a challenge for clinicians. The disease is usually detected in an advanced stage which precludes curative treatment. We assume that only new and non-invasive biomarkers allowing earlier detection will result in better patient management and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lagniau, Sabrina, Lamote, Kevin, van Meerbeeck, Jan P., Vermaelen, Karim Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581147/ https://www.ncbi.nlm.nih.gov/pubmed/28881848 http://dx.doi.org/10.18632/oncotarget.17910

Ejemplares similares

Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research
por: Janssens, Eline, et al.
Publicado: (2022)

Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis
por: Schillebeeckx, Eline, et al.
Publicado: (2021)

Investigational Approaches for Mesothelioma
por: Surmont, Veerle F., et al.
Publicado: (2011)

Moonshots for aging
por: Kumar, Sandeep, et al.
Publicado: (2020)

External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma
por: Janssens, Eline, et al.
Publicado: (2022)

Moonshot thinking in periodontology
por: Park, Jung-Chul, et al.
Publicado: (2021)

Why We Do Need Another Medical Journal…
por: Malbrain, Manu L. N. G.
Publicado: (2013)

Do we really need another risk prediction rule? Yes, we do
por: Lo, Alexander X., et al.
Publicado: (2022)

A new phase of the Cancer Moonshot to end cancer as we know it
por: Singer, Dinah S.
Publicado: (2022)

Moonshot Science—Risks and Benefits
por: Casadevall, Arturo, et al.
Publicado: (2016)

Achieving the cancer moonshot in Africa
por: Adewole, Isaac, et al.
Publicado: (2022)

Do we need another neural correlate of contour integration?
por: de-Wit, Lee, et al.
Publicado: (2014)

Statins in heart failure: do we need another trial?
por: Bonsu, Kwadwo Osei, et al.
Publicado: (2013)

Mesothelioma treatment: Are we on target? A review
por: Hiddinga, Birgitta I., et al.
Publicado: (2015)

Treatment of Iatrogenic esophageal perforation: Do we need another tool?
por: Barthet, Marc, et al.
Publicado: (2015)

Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?
por: Nakamura, Akifumi, et al.
Publicado: (2023)

CEPI launches 100-day vaccine “moonshot”
por: Usher, Ann Danaiya
Publicado: (2022)

The Impact of the Cancer Moonshot on Cardio-Oncology Science
por: Minasian, Lori M., et al.
Publicado: (2022)

Do we need another prognostic score for cardiogenic shock patients with ECMO?
por: Champion, Sébastien
Publicado: (2017)

Paradigm Shifts of Heart Failure Therapy: Do We Need Another Paradigm?
por: Lee, Hae-Young, et al.
Publicado: (2020)

Moonshots and metastatic disease: the need for a multi-faceted approach when studying atypical responses
por: De La Torre, Kristine, et al.
Publicado: (2017)

Moonshots en la educación : nuevas tecnologías y aprendizaje mixto en el aula /
por: Wojcicki, Esther
Publicado: (2016)

The economics of moonshots: Value in rare disease drug development
por: Yates, Nathan, et al.
Publicado: (2022)

Do We Really Need Another Special Issue on NF-κB in Cancer and Inflammation?
por: Geismann, Claudia, et al.
Publicado: (2019)

Moonshot!: game-changing strategies to build billion-dollar businesses
por: Sculley, John
Publicado: (2014)

Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
por: Papadakos, Stavros P., et al.
Publicado: (2022)

Do We Need Biomarkers for Disc Degeneration?
por: Gruber, Helen E., et al.
Publicado: (2007)

Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study
por: Lamote, Kevin, et al.
Publicado: (2017)

Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on
por: Ledda, Caterina, et al.
Publicado: (2018)

Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma
por: Martínez-Rivera, Vanessa, et al.
Publicado: (2018)

Discovery of new biomarkers for malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2015)

Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020)

Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
por: Ricciardi, Sara, et al.
Publicado: (2021)

Cancer Moonshot 2020: a new march of clinical and translational medicine
por: Wang, Xiangdong
Publicado: (2016)

Thoracoscopy in Pleural Malignant Mesothelioma Diagnosis
por: Tassi, G. F., et al.
Publicado: (1997)

Update on the pathologic diagnosis of malignant mesothelioma
por: Schulte, Jefree J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
por: Bibby, Anna C., et al.
Publicado: (2016)

Serum Calretinin as a Biomarker in Malignant Mesothelioma
por: Zupanc, Cita, et al.
Publicado: (2021)

Characteristics of patient navigation programs in the Cancer Moonshot ACCSIS colorectal cancer screening initiative
por: Coronado, Gloria D, et al.
Publicado: (2023)

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
por: Cantini, Luca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qi9p1jb21m8r8bnsan40u2a59j